Mode of action of NuCana's ProTides compared to those of gemcitabine (above). © NuCana plc

Scotch cancer corp NuCana plc was up 3% (to US$18.61) after closing an initial public offering on Friday led by Citigroup, Jefferies and Cowen and co-managed by William Blair.

Up to recently, it was not possible for academic researchers to visualise the spatial distribution of intratumoural heterogeneity within solid tumours. An international research team has now reported a way to track changes with whole-tissue biospy phenotyping.

Sébastien Stoitzner, CEO. © Gensearch

The European Biotech market is extremely dynamic, acknowledged as being number two in the world of market rankings. This is a cause for celebration!

Mode of action of caplacizumab. © Ablynx

Belgian nanobody developer Ablynx NV‘s nanobody caplacizumab has met relevant endpoints in the pivotal Hercules Phase III study in patients with thrombotic thrombocytopenic purpura (aTTP),  paving the way to market authorisation in Europe and the US.

© Sartorius

Active sampling of airborne viruses, bacteria, yeasts and fungi.

Jesper Ericsson

Symcel announced that Jesper Ericsson has joined Symcel as Chief Executive Officer. 

Kathryn J. Gregory

A newly-developed, fast, and cost-effective dipstick test sensitively and specifically identified Zika virus and all four dengue virus subtypes without any detectable cross-reactivity. 

The ASEBIO Investor Day took place in the Barcelona Science Parc. © ASEBIO
The Spanish biotech sector is growing. This attracts more and more international investors. End of September ASEBIO organised the first edition of an Investor Day. 

German CRO Evotec AG announced an €15m investment in British Exscienta Ltd. to push artificial intelligence (AI)-driven drug discovery.

Mode of action of daramutumab, © Genmab A/S

Danish Genmab A/S has received market approval in Japan for its anti-CD38 antibody daratumumab (DARZALEX®) as therapy for relapsed or refractory Multiple Myeloma.